Get the Stockscreener App
9.995
2.43%
-0.285
Treace Medical Concepts Inc stock is traded at $9.995, with a volume of 119.66K.
It is down -2.43% in the last 24 hours and up +31.11% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
See More
Previous Close:
$10.28
Open:
$10.28
24h Volume:
119.66K
Relative Volume:
0.25
Market Cap:
$640.41M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-9.7779
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-0.20%
1M Performance:
+31.11%
6M Performance:
+54.31%
1Y Performance:
-29.42%
1-Day Range:
$9.99
$10.40
1-Week Range:
$9.64
$10.79
52-Week Range:
$3.92
$15.98
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
10.00 | 640.41M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
129.06 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.44 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.18 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.99 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.17 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap UpStill a Buy? - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Upgraded at BTIG Research - Armenian Reporter
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 - The Manila Times
Treace Medical Earnings: Bunion Surgery Leader Reports Q4 Results & Growth Outlook - StockTitan
BTIG raises Treace Medical stock to Buy, sets $16 target - MSN
Why Treace Medical Concepts (TMCI) Is Rallying Today - Insider Monkey
BTIG Upgrades Treace Medical Concepts to Buy From Neutral, Price Target is $16 -February 04, 2025 at 07:33 am EST - Marketscreener.com
Treace Medical Concepts (NASDAQ:TMCI) Stock Rating Upgraded by BTIG Research - MarketBeat
Morgan Stanley Reduces Stake in Treace Medical Concepts Inc - GuruFocus.com
Treace Medical Concepts, Inc. Announces First Surgical Cases Utilizing the Speedakin Anatomic Compression Implant - Marketscreener.com
Revolutionary Bunion Surgery Implant Eliminates Metal Allergy RiskTreace Medical's Latest Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Shares Up 5.1%Time to Buy? - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Purchased by Barclays PLC - Defense World
Barclays PLC Increases Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Rockets 26% But Many Are Still Ignoring The Company - Simply Wall St
Treace Medical Concepts reports Q4 preliminary revenue of $68.4M$68.8M - MSN
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target at $8.98 - Defense World
JPMorgan Chase & Co. Grows Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
JPMorgan Chase & Co. Has $7.32 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
TMCI Stock May Gain From the Limited Release of the Percuplasty System - MSN
Treace Medical Concepts (NASDAQ:TMCI) Trading 10.3% HigherTime to Buy? - MarketBeat
Treace Medical Concepts Reports Strong 2024 Revenue Growth - TipRanks
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue - The Manila Times
Treace Medical Q4 Revenue Hits $68.8M as Bunion Surgery Network Expands to 3,135 Surgeons - StockTitan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Reduced by Geode Capital Management LLC - Defense World
Barclays PLC Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Insiders Of Treace Medical Concepts Are Up 58% On Their US$7.31m Purchase - Simply Wall St
Franklin Resources Inc. Acquires Shares of 36,487 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on Bunion Surgery Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital - Defense World
Lake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy Recommendation - MSN
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday - Benzinga
Treace Medical Concepts (NASDAQ:TMCI) Now Covered by Analysts at Lake Street Capital - MarketBeat
Lake Street initiates Buy rating on Treace Medical stock, highlighting 15% growth potential - Investing.com
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure - The Manila Times
Treace Medical Launches Groundbreaking Minimally Invasive Bunion Surgery System Targeting 450,000 Annual Procedures - StockTitan
Who Holds the Power? Discover the Forces Behind Treace Medical Concepts! - Jomfruland.net
With 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big guns - Yahoo Finance
State Street Corp Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
10,003 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by HighTower Advisors LLC - Defense World
Stifel Financial Corp Has $776,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.88 Average PT from Brokerages - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Fmr LLC Purchases 54,353 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. announced that it expects to receive $2.1 million in funding - Marketscreener.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
Analysts Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $7.88 - MarketBeat
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Treace Medical Concepts Inc Stock (TMCI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Scanlan Sean F. | Chief Innovation Officer |
Sep 12 '24 |
Option Exercise |
0.10 |
33,750 |
3,280 |
250,074 |
| TREACE JAMES T | Director |
Aug 15 '24 |
Buy |
5.96 |
84,000 |
501,035 |
1,223,441 |
| Treace John T. | Chief Executive Officer |
Aug 14 '24 |
Buy |
6.00 |
85,000 |
510,314 |
6,473,095 |
| Treace John T. | Chief Executive Officer |
Jun 11 '24 |
Buy |
5.88 |
45,000 |
264,600 |
6,388,095 |
| TREACE JAMES T | Director |
May 31 '24 |
Buy |
6.05 |
25,000 |
151,328 |
1,139,441 |
| TREACE JAMES T | Director |
May 29 '24 |
Buy |
5.20 |
25,000 |
130,062 |
1,114,441 |
| TREACE JAMES T | Director |
May 28 '24 |
Buy |
5.07 |
50,000 |
253,475 |
1,089,441 |
| MOTT RICHARD W | Director |
May 22 '24 |
Buy |
4.99 |
12,100 |
60,425 |
1,054,944 |
| Treace John T. | Chief Executive Officer |
May 17 '24 |
Buy |
5.56 |
100,000 |
556,170 |
6,343,095 |
| Kiernan Jane E | Director |
May 14 '24 |
Buy |
5.17 |
19,356 |
100,001 |
24,941 |
0.86%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):